UnknownPhase 4

Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume

25 participantsStarted 2023-04-01

Plain-language summary

To evaluate the effects of local intravesical B.C.G and gemcitabine on semen quality and testicular volume.

Age range20 Years – 60 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Male patients from 20 to 60's year old (the years of reproductive active men)
✓. Non muscle invasive bladder (T1 or less) urothelial carcinoma who are elected to intravesical immunotherapy or chemotherapy after TURT

decrease of one or more semen parameters

Timeframe: after 3 month of the 1st semen analysis

NCT IDNCT05701332

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-01

Ahmed A Elsayed, resident